Search Results - "SCHWÄBLE, J"
-
1
Bis(1H-2-indolyl)-1-methanones as inhibitors of the hematopoietic tyrosine kinase Flt3
Published in Leukemia (01-08-2002)“…Aberrant expression and activating mutations of the class III receptor tyrosine kinase Flt3 (Flk-2, STK-1) have been linked to poor prognosis in acute myeloid…”
Get full text
Journal Article -
2
Expression of the p14 tumor suppressor predicts survival in acute myeloid leukemia
Published in Leukemia (01-04-2004)Get full text
Journal Article -
3
Oncogenic receptor tyrosine kinase in leukemia
Published in Cellular and molecular biology (Noisy-le-Grand, France) (01-09-2003)“…Growth, survival and differentiation of hematopoietic cells are regulated by the interaction between hematopoietic growth factors and their receptors. While…”
Get more information
Journal Article -
4
-
5
Expression of the p14ARF tumor suppressor predicts survival in acute myeloid leukemia
Published in Leukemia (01-04-2004)“…Cell cycle aberrations are associated with therapy outcome in many types of cancer. We analyzed mRNA expression levels of 18 cell cycle-related genes in bone…”
Get full text
Journal Article -
6
Neuroblastoma: induction of differentiation (Part I). Basical science in pediatric surgery
Published in European journal of pediatric surgery (01-04-2000)“…Neuroblastoma is the second-most common solid tumor in childhood. The majority of patients have a very poor outcome due to aggressive growth and metastatic…”
Get more information
Journal Article -
7
Mutations of growth factor receptor Flt3 in acute myeloid leukemia: transformation of myeloid cells by Ras-dependent and Ras-independent mechanisms
Published in Deutsche medizinische Wochenschrift (18-10-2002)“…The tyrosine kinase receptor Flt3 mediates important functions in early hematopoietic progenitors. Recently mutations of a growth factor receptor have been…”
Get more information
Journal Article -
8
AML-associated Flt3 kinase domain mutations show signal transduction differences compared with Flt3 ITD mutations
Published in Blood (01-07-2005)“…Activating mutations of Flt3 are found in approximately one third of patients with acute myeloid leukemia (AML) and are an attractive drug target. Two classes…”
Get full text
Journal Article -
9
Suppression of myeloid transcription factors and induction of STAT response genes by AML-specific Flt3 mutations
Published in Blood (15-04-2003)“…The receptor tyrosine kinase Flt3 is expressed and functionally important in early myeloid progenitor cells and in the majority of acute myeloid leukemia (AML)…”
Get full text
Journal Article -
10
Flt3 tandem duplication mutations cooperate with Wnt signaling in leukemic signal transduction
Published in Blood (01-05-2005)“…Activating Flt3 mutations occur in about 30% of patients with acute myeloid leukemia (AML), often as in-frame internal tandem duplication (ITD) at the…”
Get full text
Journal Article -
11
Identification of metastasis-associated receptor tyrosine kinases in non-small cell lung cancer
Published in Cancer research (Chicago, Ill.) (01-03-2005)“…Development of distant metastasis after tumor resection is the leading cause of death in early-stage non-small cell lung cancer (NSCLC). Receptor tyrosine…”
Get full text
Journal Article -
12
The molecular pathogenesis of acute myeloid leukemia
Published in Critical reviews in oncology/hematology (01-11-2005)“…The description of the molecular pathogenesis of acute myeloid leukemias (AML) has seen dramatic progress over the last years. Two major types of genetic…”
Get full text
Journal Article -
13
RGS2 is an important target gene of Flt3-ITD mutations in AML and functions in myeloid differentiation and leukemic transformation
Published in Blood (01-03-2005)“…Activating fetal liver tyrosine kinase 3 (Flt3) mutations represent the most common genetic aberrations in acute myeloid leukemia (AML). Most commonly, they…”
Get full text
Journal Article -
14
High-Throughput Analysis of Genome-Wide Receptor Tyrosine Kinase Expression in Human Cancers Identifies Potential Novel Drug Targets
Published in Clinical cancer research (15-02-2004)“…Novel high-throughput analyses in molecular biology allow sensitive and rapid identification of disease-related genes and drug targets. We have used…”
Get full text
Journal Article -
15
Flt3 receptor tyrosine kinase as a drug target in leukemia
Published in Current pharmaceutical design (01-01-2004)“…The hematopoietic class III receptor tyrosine kinase (RTK) Flt3 (Flk2, STK1) has recently received much attention as a potential drug target. Activation of…”
Get more information
Journal Article -
16
The serine-threonine kinase MNK1 is post-translationally stabilized by PML-RARα and regulates differentiation of hematopoietic cells
Published in Oncogene (09-12-2004)“…Microarray analyses were performed to identify target genes that are shared by the acute myeloid leukemia (AML) translocation products PML-RARα, PLZF-RARα and…”
Get full text
Journal Article